168 related articles for article (PubMed ID: 30268472)
21. CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients.
Shi WL; Li J; Du YJ; Zhu WF; Wu Y; Hu YM; Chen YC
Med Oncol; 2013 Dec; 30(4):755. PubMed ID: 24178178
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of circulating tumor cells in patients with small cell lung cancer.
Naito T; Tanaka F; Ono A; Yoneda K; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Kenmotsu H; Shukuya T; Kaira K; Koh Y; Endo M; Hasegawa S; Yamamoto N
J Thorac Oncol; 2012 Mar; 7(3):512-9. PubMed ID: 22258473
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy.
Aggarwal C; Wang X; Ranganathan A; Torigian D; Troxel A; Evans T; Cohen RB; Vaidya B; Rao C; Connelly M; Vachani A; Langer C; Albelda S
Lung Cancer; 2017 Oct; 112():118-125. PubMed ID: 29191584
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.
Spiliotaki M; Mavroudis D; Kapranou K; Markomanolaki H; Kallergi G; Koinis F; Kalbakis K; Georgoulias V; Agelaki S
Breast Cancer Res; 2014 Nov; 16(6):485. PubMed ID: 25432416
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
[TBL] [Abstract][Full Text] [Related]
26. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
27. Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells.
Su Z; Wang Z; Ni X; Duan J; Gao Y; Zhuo M; Li R; Zhao J; Ma Q; Bai H; Chen H; Wang S; Chen X; An T; Wang Y; Tian Y; Yu J; Wang D; Xie XS; Bai F; Wang J
Clin Cancer Res; 2019 Aug; 25(16):5049-5060. PubMed ID: 31113842
[TBL] [Abstract][Full Text] [Related]
28. Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane.
Spiliotaki M; Kallergi G; Nikolaou C; Xenidis N; Politaki E; Apostolaki S; Georgoulia N; Koinis F; Tsoukalas N; Hatzidaki D; Kotsakis A; Georgoulias V
Cancer Chemother Pharmacol; 2021 Feb; 87(2):277-287. PubMed ID: 33515073
[TBL] [Abstract][Full Text] [Related]
29. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
Zhu HH; Liu YT; Feng Y; Zhang LN; Zhang TM; Dong GL; Xing PY; Wang HY; Shi YK; Hu XS
Thorac Cancer; 2021 Oct; 12(20):2749-2757. PubMed ID: 34423906
[TBL] [Abstract][Full Text] [Related]
30. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
31. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.
Androulakis N; Agelaki S; Perraki M; Apostolaki S; Bozionelou V; Pallis A; Kalbakis K; Xyrafas A; Mavroudis D; Georgoulias V
Br J Cancer; 2012 Jun; 106(12):1917-25. PubMed ID: 22669159
[TBL] [Abstract][Full Text] [Related]
33. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
[No Abstract] [Full Text] [Related]
34. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor.
Hiltermann TJN; Pore MM; van den Berg A; Timens W; Boezen HM; Liesker JJW; Schouwink JH; Wijnands WJA; Kerner GSMA; Kruyt FAE; Tissing H; Tibbe AGJ; Terstappen LWMM; Groen HJM
Ann Oncol; 2012 Nov; 23(11):2937-2942. PubMed ID: 22689177
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
Salgia R; Weaver RW; McCleod M; Stille JR; Yan SB; Roberson S; Polzer J; Flynt A; Raddad E; Peek VL; Wijayawardana SR; Um SL; Gross S; Connelly MC; Morano C; Repollet M; Sanders R; Baeten K; D'Haese D; Spigel DR
Invest New Drugs; 2017 Jun; 35(3):334-344. PubMed ID: 28299514
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of circulating tumor cells in patients with small-cell lung cancer.
Wang YL; Liu CH; Li J; Ma XP; Gong P
Tumori; 2017 May; 103(3):242-248. PubMed ID: 28218384
[TBL] [Abstract][Full Text] [Related]
37. A Modified Method to Isolate Circulating Tumor Cells and Identify by a Panel of Gene Mutations in Lung Cancer.
Wang H; Wu J; Zhang Q; Hao J; Wang Y; Li Z; Niu H; Zhang H; Zhang S
Technol Cancer Res Treat; 2021; 20():1533033821995275. PubMed ID: 34032165
[TBL] [Abstract][Full Text] [Related]
38. Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer.
Georgoulias V; Apostolaki S; Bozionelou V; Politaki E; Perraki M; Georgoulia N; Kalbakis K; Kotsakis A; Xyrafas A; Agelaki S; Mavroudis D
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1217-25. PubMed ID: 25344760
[TBL] [Abstract][Full Text] [Related]
39. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.
Hou JM; Greystoke A; Lancashire L; Cummings J; Ward T; Board R; Amir E; Hughes S; Krebs M; Hughes A; Ranson M; Lorigan P; Dive C; Blackhall FH
Am J Pathol; 2009 Aug; 175(2):808-16. PubMed ID: 19628770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
